Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
4.960
+0.140 (2.90%)
Nov 21, 2024, 4:00 PM EST - Market closed
MRVI Analyst Ratings
Total Analysts
11
Consensus Rating
Buy
Price Target
$10.33
Upside
+108.27%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wolfe Research | Wolfe Research | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Nov 14, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $17 → $13 | Buy | Maintains | $17 → $13 | +162.10% | Nov 8, 2024 |
| William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Nov 8, 2024 |
| Baird | Baird | Buy Maintains $10 → $9 | Buy | Maintains | $10 → $9 | +81.45% | Nov 8, 2024 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $8 → $7 | Hold | Maintains | $8 → $7 | +41.13% | Oct 8, 2024 |
| Wells Fargo | Wells Fargo | Buy Initiates $10 | Buy | Initiates | $10 | +101.61% | Aug 27, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $15 | Buy | Reiterates | $15 | +202.42% | Aug 16, 2024 |
| Morgan Stanley | Morgan Stanley | Buy → Hold Downgrades $11 → $10 | Buy → Hold | Downgrades | $11 → $10 | +101.61% | Aug 13, 2024 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $7 → $8 | Hold | Maintains | $7 → $8 | +61.29% | Aug 8, 2024 |
| UBS | UBS | Hold Maintains $8.5 → $11 | Hold | Maintains | $8.5 → $11 | +121.77% | Aug 8, 2024 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $8 → $7 | Hold | Maintains | $8 → $7 | +41.13% | Jul 9, 2024 |
| Baird | Baird | Buy Maintains $8 → $10 | Buy | Maintains | $8 → $10 | +101.61% | May 9, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +202.42% | Apr 10, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $12 → $14 | Buy | Maintains | $12 → $14 | +182.26% | Feb 23, 2024 |
| Stifel | Stifel | Strong Buy Maintains $11 → $10 | Strong Buy | Maintains | $11 → $10 | +101.61% | Feb 23, 2024 |
| B of A Securities | B of A Securities | Hold → Strong Buy Upgrades $10 → $8 | Hold → Strong Buy | Upgrades | $10 → $8 | +61.29% | Dec 12, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.